Inhibition of hepatic macromolecule synthesis by single doses of N-hydroxy-2-fluorenylacetamide.
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D002250:Carbon Radioisotopes; D004247:DNA / Q000096:biosynthesis*; D005449:Fluorenes / Q000494:pharmacology*; D006877:Hydroxamic Acids / Q000494:pharmacology; D007668:Kidney / Q000276:immunology; D008099:Liver / Q000378:metabolism*; D008115:Liver Regeneration / Q000187:drug effects; D008297:Male; D009401:Nephrosis / Q000378:metabolism; D009963:Orotic Acid / Q000378:metabolism; D014176:Protein Biosynthesis; D011507:Proteinuria; D012313:RNA / Q000096:biosynthesis*; D051381:Rats; D012756:Sheep / Q000276:immunology; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D000596:Amino Acids; D002250:Carbon Radioisotopes; D005449:Fluorenes; D006877:Hydroxamic Acids; D014316:Tritium; D009963:Orotic Acid; D012313:RNA; D004247:DNA; D013936:Thymidine